Methods, compositions, systems, apparatuses and kits for nucleic acid amplification

Patent metadata

Field	Value
Publication number	US-12351865-B2
Application number	US-202318104548-A
Country	US
Kind code	B2
Filing date	Feb 1, 2023
Priority date	Dec 17, 2010
Publication date	Jul 8, 2025
Grant date	Jul 8, 2025

Abstract

Novel methods of generating a localized population of immobilized clonal amplicons on a support are provided.

First claim

The invention claimed is:

1. A method of primer extension in isothermal conditions, comprising:
a) hybridizing a first primer molecule (“first forward primer”) to a complementary primer-binding sequence (“reverse-strand PBS”) on a nucleic acid strand (“reverse strand”); wherein the first forward primer is immobilized to a solid support;
b) generating an extended first forward strand that is a full-length complement of the reverse strand and is hybridized thereto, by extending the first forward primer molecule using the reverse strand as template;
c) causing or allowing the double-stranded reverse-strand PBS to denature or breathe;
d) hybridizing a second primer molecule (“second forward primer”) to the reverse-strand PBS where the reverse strand is also hybridized to the first forward strand; wherein the second forward primer is immobilized to the solid support.

2. The method of claim 1 , comprising amplifying the forward strand by one or more amplification cycles comprising steps (b), (c), and (d), wherein the second forward primer of step (d) of a first amplification cycle is the first forward primer of step (b) of a subsequent amplification cycle; and wherein a substantial proportion of reverse strands are hybridized to forward strands at all times during or between said one or more repetitions.

3. The method of claim 2 , wherein the substantial proportion of reverse strands is at least 30%, 40%, 50%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% of reverse strands.

4. The method of claim 1 , comprising amplifying the reverse strand in isothermal conditions by:
a) hybridizing a first reverse primer molecule to a complementary reverse-primer-binding sequence (“forward-strand PBS”) on an extended forward strand;
b) generating an extended first reverse strand that is a full-length complement of the forward strand and hybridized thereto, by extending the first reverse primer molecule in template-dependent fashion using the forward strand as template;
c) causing or allowing the double-stranded forward-strand PBS to denature or breathe;
and
d) hybridizing a second primer (“second reverse primer”) to the forward-strand PBS where the forward strand is also hybridized to the first reverse strand.

5. The method of claim 4 , comprising amplifying the reverse strand by one or more repetitions of steps (b)-(d), wherein the second reverse primer of step (d) is the first reverse primer of repeated step (b); and wherein a substantial proportion of forward strands are hybridized to reverse strands at all times during or between said one or more repetitions.

6. The method of claim 5 , wherein the substantial proportion of forward strands is at least 30%, 40%, 50%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99% of reverse strands.

7. The method of claim 4 , wherein the first and/or second reverse primers are immobilized to a single support.

8. The method of claim 1 , further comprising completely separating the extended forward strands from reverse strands after performing the desired number of amplification cycles, and optionally removing separated forward strands from the presence of separated reverse strands, or vice versa.

9. The method of claim 1 , wherein during one or more amplification cycles all nucleic acid reagents are not in contact with a recombinase or reverse transcriptase or helicase or nicking enzyme or any other enzyme that is not a polymerase at any time.

10. The method of claim 1 , wherein template-dependent extension of a forward primer using a reverse strand as template results in displacement of another forward strand that was already hybridized to the reverse strand.

11. The method of claim 1 , wherein the Tm of all forward primers is not more than 50° C., 55° C., 60° C. or 65° C., and wherein the Tm of the reverse strands is not less than 95° C., 90° C., 85° C., 80° C. or 75° C.

12. The method of claim 1 , wherein the isothermal conditions are adjusted to a temperature that is higher than the Tm of all forward primers, but lower than the Tm of the reverse strands, wherein the Tm of a reverse strand is the temperature at which half of the reverse strands in a clonal population of identical reverse strands are fully denatured from a perfectly complementary strand that is fully hybridized to the reverse strand across its entire length.

13. The method of claim 1 , wherein said first and second forward primers are adjacently immobilized to the same support, whereby amplification generates an immobilized clonal populations of extended forward strands.

14. The method of claim 1 , wherein a plurality of template nucleic acids are individually hybridized to spatially-separated immobilization sites, whereby amplification generates spatially-separated clonal populations corresponding to individual template nucleic acids.

15. The method of claim 1 , wherein denaturation is non-enzymatic.

16. A composition comprising: a double-stranded nucleic acid comprising a reverse strand and a forward strand, the reverse strand comprising a primer-binding sequence (“reverse-strand PBS”), the forward strand not hybridized to the reverse-strand PBS, and a second primer molecule (“second forward primer”) hybridized to the reverse-strand PBS, wherein the second forward primer is immobilized to a solid support, wherein at least 60% of nucleotide bases of the second forward primer are adenine, thymine or uracil or are complementary to adenine, thymine or uracil.

17. The composition of claim 16 , comprising clonal populations of nucleic acid strands (“reverse strands”), optionally wherein individual reverse strands of each clonal population comprise a low-melt (e.g., breathable) primer-binding sequence at the 3′ end and/or a low-melt primer sequence on the 5′ end.

Assignees

• Life Technologies Corp

Inventors

• Li Bin
• Lao Kai Qin
• O'Neil Jennifer
• Kunkel Jennifer
• Haley Kellie
• Kasinskas Rachel
• Ma Zhaochun
• Brzoska Pius

Classifications

• C12Q1/46

  involving cholinesterase · CPC title

• C12Q1/6834

  Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title

• C12Q1/6874

  involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

• C12Q1/6869

  Methods for sequencing · CPC title

• C12P19/34

  Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title